468 results on '"BUSCH, Theresa M."'
Search Results
2. A novel investigational preclinical model to assess fluence rate for dental oral craniofacial tissues
3. Three-dimensional printing of the human lung pleural cavity model for PDT malignant mesothelioma
4. Advances in Radiation Therapy for Malignant Pleural Mesothelioma
5. Figure S3 from Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer
6. Data from Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer
7. Supplementary Table 2 from Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer
8. Supplementary Table 1 from Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer
9. First-In-Human Computer-Optimized Endobronchial Ultrasound-Guided Interstitial Photodynamic Therapy for Patients With Extrabronchial or Endobronchial Obstructing Malignancies
10. Ultrafast Tracking of Oxygen Dynamics During Proton FLASH
11. Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer
12. Assessing 661nm photobiomodulation light fluence rate transmission for optimal dose delivery
13. Red and near-infrared light dosimetry: a comprehensive analysis of tissue optical properties
14. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System
15. Theranostic Phthalocyanine and Naphthalocyanine Nanoparticles for Photoacoustic Imaging and Photothermal Therapy of Tumors
16. Combined fluorescence-guided surgery and photodynamic therapy for glioblastoma multiforme using cyanine and chlorin nanocluster
17. Supplementary Figure 5 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
18. Supplementary Figure 1 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
19. FIGURE 3 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
20. Supplementary Figure 2 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
21. Supplementary Figure 3 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
22. FIGURE 7 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
23. FIGURE 6 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
24. FIGURE 5 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
25. Supplementary Figure 4 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
26. Data from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
27. FIGURE 1 from Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
28. Photooxidative vulnerability to intralipid in photodynamic therapy
29. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma
30. Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy
31. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
32. Fractionated Photofrin-Mediated Photodynamic Therapy Significantly Improves Long-Term Survival.
33. Tumor Microenvironment as a Determinant of Photodynamic Therapy Resistance
34. Data from The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation
35. Supplementary Figures 1-9; Supplementary Table 1 from The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation
36. Supplementary Methods, Figure Legends 1-3 from Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy
37. Figure SF6 from FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
38. Table ST1 from FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
39. Data from Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy
40. Supplementary Figure 3 from Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy
41. Supplementary Figure 2 from Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy
42. Supplementary Figure 1 from Tumor Vascular Microenvironment Determines Responsiveness to Photodynamic Therapy
43. Data from Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms
44. Supplemental Methods from FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
45. Supplemental Figures 1-7 from Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms
46. Supplemental Materials and Methods from Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms
47. Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors
48. Chlorin e6-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters as a Theranostic Agent for Dual-Mode Imaging and Photodynamic Therapy
49. Oxidative Stress and Photodynamic Therapy for Prostate Cancer
50. A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.